dupixent enrollment form for asthma


I understand that I do not have to enroll in the Program or receive the Communications, and that I can still receive DUPIXENT, as prescribed by my physician. Marketing communications will not be sent to patients under the age of 18. Actual results may differ from the forward-looking information.MiscellaneousThe Terms of Use constitute the entire agreement between you and Lash relating to the Site. Use Especially tell your healthcare provider if you are taking oral, topical, or inhaled corticosteroid medicines or use an asthma medicine. website and/or database producer. To get more information about the registry call. In clinical trials, Dupixent reduced severe exacerbations and oral corticosteroid use and improved lung function These are not all the possible side effects of DUPIXENT. … Dupixent HMSA – 04/2020. SM. Further, Lash and any of our affiliates shall be free to use such information, including, but not limited to, any ideas, concepts, know-how, or techniques contained therein, for any purpose whatsoever, including, but not limited to, researching, developing, manufacturing, and marketing products incorporating such information.Non-identifiable Data and How We Use ItThis Site also collects non-identifiable data including web logs, pages visited, operating systems, and web browser type (Windows, Safari, Mozilla, Safari, etc.) I am interested in receiving DUPIXENT information and resources. 200-mg/1.14-mL or 300-mg/2-mL single-use prefilled … You must be 18 years or older to sign up. Dupixent® 200mg PFS w/Shield Asthma Atopic Dermatitis Load: Inject 400mg subcutaneously (2-200mg syringes in different injection sites) on Day 1, then 200mg on Day 15, ... Fasenra® Fax completed Fasenra Access 360TM Enrollment Form to Kroger Specialty Pharmacy at 844.306.0200 Limitation of Use DUPIXENT … Lash shall not directly or indirectly sell, loan, trade, or lease any PHI obtained through the Site with any third parties. Learn about DUPIXENT® (dupilumab) for moderate-to-severe asthma treatment. Patient Refills: 888-777-5547 Prescriber questions or help: 855-460-7928 Fax: 888-777-5645 All other inquiries: 888-777-5547 are pregnant or plan to become pregnant. My asthma doctor thought the sinus infection was related to my asthma so I had sinus surgery where they discovered many polyps. Data in children aged 6-11 further suggest Dupixent has potential to be best-in-class treatment option Dupixent significantly reduced severe asthma attacks by up to 65% over one year compared to placebo DUPIXENT can cause serious side effects, including: The most common side effects in patients with asthma include injection site reactions, pain in the throat (oropharyngeal pain), and high count of a certain white blood cell (eosinophilia). I understand that I can opt out from future text messages at any time by texting TEXTOUT to 39771 from my mobile phone, and that I can get help for text messages by texting TEXTHELP to 39771. Any claim or cause of action arising out of or related to the Site or the Terms of Use must be filed within one year after such claim or cause of action arose. FDA accepts Dupixent® (dupilumab) for review in children with moderate-to-severe asthma Submission supported by data demonstrating Dupixent significantly reduced severe asthma … You are encouraged to report negative side effects of prescription drugs to the FDA. Lash shall provide you with the PHI within a reasonable time from the date of the request; make available PHI for amendment within a reasonable time of receipt of a written request and incorporate any amendments to the PHI within ten (10) business days in accordance with the Privacy Rule of HIPAA in the event that the PHI in Lash's possession constitutes a Designated Record Set; provide you with an accounting of disclosures for individual in the form required by 45 C.F.R. 164.528 within a reasonable time of your request; make its internal practices, books and records relating to the use and disclosure of PHI available to you and the Secretary of HHS or designee for purposes of determining your compliance with the Privacy Rule; and. Once you’ve been prescribed DUPIXENT, your healthcare provider can download the enrollment form, help you fill it out, and fax it back to DUPIXENT MyWay at 1-844-387-9370. Prescription & Enrollment Form Dupixent® (dupilumab) Please fax completed form to your team at 808.650.6487. Rarely, this can happen in people with asthma who receive Dupixent. DUPIXENT safely and effectively. Visit the Dupixent website or call 1-844-387-4936 to see if you are eligible for the savings program. Please note: By clicking on this link, you will be leaving this Sanofi-hosted US website and going to another, entirely independent website. For atopic dermatitis and asthma patients taking an initial 600 mg dose, administer each of the two DUPIXENT 300 mg injections at different injection sites. I authorize the Alliance to contact me by mail, telephone, or email, with information about the Program, moderate-to-severe asthma and products, promotions, services and research studies, and to ask my opinion about such information and topics, including market research and disease-related surveys. To enroll in DUPIXENT MyWay, your patients can call 1-844-DUPIXEN(T) (1-844-387-4936) or download and fill out the following forms with your assistance. to provide you with additional information about products or services (of ours and of others) that may be of interest to you. Although Lash make a genuine effort to ensure the security of such information and the transactions conducted on the Site, including employing appropriate encryption technology, Lash can not guarantee the security of the information, nor can Lash guarantee that information you supply will not be intercepted while being transmitted via the Site. If your healthcare provider decides that you or a caregiver can give DUPIXENT injections, you or your caregiver should receive training on the right way to prepare and inject DUPIXENT. the patient designated below to be given the therapy (Dupixent injections) over an extended period of time and at specified intervals, as prescribed by Princeton Allergy and Asthma. Such services include medication and adherence communications and support, medication dispensing support, coverage and financial assistance support, disease and medication education, injection training and other support services (the "Services"). Dupixent is injected under the skin, usually once every 2 to 4 weeks. Enrollment Form 2 Patient Name DOB Prescriber Name NPI# Respiratory Please click here for the full Prescribing Information. are breastfeeding or plan to breastfeed. After the sinus surgery I was right back to the same conditions as before. Prescription & Enrollment Form Dupixent® (dupilumab) Please fax completed form to your team at 866.531.1025. Box 5925 Mailstop 55A-220A Bridgewater, NJ 08807. The most secure digital platform to get legally binding, electronically … I further hereby give authorization and consent for treatment, from Princeton Allergy and Asthma … The Phase III trial was evaluating the efficacy and safety of Dupixent in addition to SOC maintenance therapy of medium … It is not known whether DUPIXENT passes into your breast milk. Limitation of Use DUPIXENT is not indicated for the relief of acute bronchospasm or status asthmaticus . The patient must be 12 years of age or older to sign up. to comply with any applicable law or regulation, court order or other legal process. Sanofi US and Regeneron provide these links as a service to its website visitors and users; however, they take no responsibility for the information on any website but their own. There is a pregnancy exposure registry for women who take DUPIXENT during pregnancy to collect information about the health of you and your baby. and version. Dupixent inhibits the overactive signaling of interleukin-4 (IL-4) and interleukin-13 (IL-13), two key proteins that contribute to the Type 2 inflammation that may underlie moderate-to-severe asthma. Box 5925 Mailstop 55A-220A Bridgewater, NJ 08807. DUPIXENT helps prevent severe asthma attacks (exacerbations) and can improve your breathing. Click on document links below to download forms, DUPIXENT MyWay Respiratory Enrollment Form, DUPIXENT MyWay Dermatology Enrollment Form, https://mothertobaby.org/ongoing-study/dupixent/. the patient designated below to be given the therapy (Dupixent injections) over an extended period of time and at specified intervals, as prescribed by Princeton Allergy and Asthma. Lash is not responsible for and does not control the contents or performance of such Web sites, and accepts no responsibility for the consequences of your use thereof.Indemnity You agree to indemnify and hold Lash, other third party service providers, and our respective affiliates, officers, directors, employees and agents harmless from and against any third party claim, action or demand and all liabilities and settlements related thereto, including without limitation, reasonable legal and accounting fees (including defense costs), resulting from, or alleged to result from, a breach of these Terms of Use or your use of the Site or its services.Forward-Looking Statements The Site may contain information that is forward-looking and involve risks and uncertainties, including, without limitation, risks and uncertainties of research and development, clinical development, regulatory approvals, our reliance on third-party manufacturers, product commercialization, competition, patents, product liability, and third-party reimbursement, and other risks and uncertainties detailed from time to time in Lash's periodic reports filed with the Securities and Exchange Commission. Yes, but I have not started taking DUPIXENT yet. DUP.21.01.0075 Dupixent is indicated in adults and adolescents 12 years and older as add-on maintenance treatment for severe asthma with type 2 inflammation characterised by raised blood eosinophils and/or raised fraction of exhaled nitric oxide (FeNO), see section 5.1, who are inadequately controlled with high dose ICS plus another medicinal product for maintenance treatment. Seek medical attention if your breathing problems get worse quickly, or if you think your asthma medications are not working as well. Asthma Enrollment Form Medications A-E (Cinqair®, Dupixent®) Six Simple Steps to Submitting a Referral 1 PATIENT INFORMATION (Complete or include demographic sheet) Patient Name: _____Address: _____City, State, ZIP: _____ DUPIXENT… Your healthcare provider can enroll you or you may enroll yourself. Asthma Enrollment Form Medications A-E (Cinqair®, Dupixent®) Six Simple Steps to Submitting a Referral 1 PATIENT INFORMATION (Complete or include demographic sheet) Patient Name: … With regard to PHI, the Site will employ appropriate administrative, physical, technical, and managerial procedures to safeguard and secure the information collected, consistent with industry practices and the sensitivity of the information provided. now approved as add-on maintenance treatment in patients (12+) with moderate-to-severe asthma with an eosinophilic phenotype or oral. US-DUP-1265a Complete entire form and fax the first 4 PAGES to DUPIXENT MyWay at 1-844-387-9370. Only asthma biologic that offers patient self-administration at home. Your email is on its way. DUPIXENT is an injection given under the skin (subcutaneous injection). You acknowledge this and that system failures may limit your ability to use the Site. You can now track shipments for all your Accredo patients. Dupixent is currently approved as an add-on treatment for patients with uncontrolled moderate-to-severe asthma aged 12 and older with elevated eosinophils or oral corticosteroid dependent asthma. Drug Dosage Dose form Cost* Dupilumab (Dupixent) 400 mg or 600 mg for initial dose, then 200 mg or 300 mg every two weeks. Tell your healthcare provider if you have any side effect that bothers you or that does not go away. DUPIXENT is a prescription medicine used with other asthma medicines for the maintenance treatment of moderate-to-severe eosinophilic or oral steroid dependent asthma in people aged 12 years and older whose asthma is not controlled with their current asthma medicines. DUPIXENT may also help reduce the amount of oral 1 PATIENT INFORMATION (Complete or include demographic sheet) CHMP recommends approval of Dupixent ® (dupilumab) for asthma indication. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088. Do not change or stop your corticosteroid medicine or other asthma medicine without talking to your healthcare provider. Only asthma biologic also approved for adult patients with moderate-to-severe atopic dermatitis, a Type 2 inflammatory disease driven by the IL-4 and IL-13 pathway. See full prescribing information for DUPIXENT. APPROVAL CRITERIA Dupixent Myway Form. Asthma Enrollment Form Medications A-E (Cinqair®, Dupixent®) Six Simple Steps to Submitting a Referral . for content, accuracy or completeness. I agree to my enrollment in the DUPIXENT MyWay Copay Card program if confirmed as eligible, understand that copay card information will be sent to my designated specialty pharmacy/in-network specialty pharmacy along with my prescription, and any assistance with my applicable cost-sharing or co-payment for DUPIXENT (dupilumab) will be made in accordance with the Program terms and conditions. DUPIXENT is indicated as an add-on maintenance treatment in patients with moderate-to-severe asthma aged 12 years and older with an eosinophilic phenotype or with oral corticosteroid dependent asthma. We’re here for you. of and access to this information is subject to 2.5 Preparation for Use of DUPIXENT 3 DOSAGE FORMS AND STR ENGTHS 4 CONTRAINDICATIONS 5 WARNINGS AND PRECAUT IONS 5.1 Hypersensitivity 5.2 Conjunctivitis and Keratitis 5.3 Eosinophilic Conditions 5.4 Acute Asthma Symptoms or Deteriorating Disease 5.5 Reduction of Corticosteroid Dosage 5.6 Patients with Co -morbid Asthma Get information and tools delivered to your phone or mailbox for support to start and stay with treatment once your doctor has prescribed the medicine. … Do not use if you are allergic to dupilumab or to any of the ingredients in DUPIXENT®. For assistance, call us at the number above, Monday–Friday, 8 am–9 pm Eastern time. You agree to assume all risk and liability arising from your use of the Site, including the risk posed by any breach in the security of communications and transactions you conduct through the Site.Lash may have access to PHI received from you and other authorized users of the Site only if that information has been de-identified in a manner consistent with HIPAA's applicable privacy and security provisions or if such access is otherwise permitted or required by law. View Terms and Conditions and Privacy Policy. Be sure to fill out your enrollment form … February 2021, https://mothertobaby.org/ongoing-study/dupixent/. Before using DUPIXENT, tell your healthcare provider about all your medical conditions, including if you: Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins and herbal supplements. GET A DUPIXENT MyWay ENROLLMENT FORM. Once you submit the Enrollment Form to DUPIXENT MyWay®, our team will perform a benefits investigation and populate a health plan’s PA with certain demographic information from the form. not use or disclose PHI other than as permitted or required by these Terms of Use or as otherwise required or permitted by law; use appropriate safeguards to prevent use or disclosure of PHI other than as provided for by these Terms of Use; report in writing to you any use or disclosure of PHI not provided for by these Terms of Use of which Lash's management becomes aware within ten (10) business days of Lash's knowledge of an unauthorized use or disclosure; mitigate, to the extent practicable, any harmful effect that is known to Lash of a use or disclosure of PHI by Lash in violation of the requirements of these Terms of Use; require all of its subcontractors and agents that receive or use, or have access to, PHI, to agree, in writing, to essentially the same restrictions and conditions on the use and/or disclosure of PHI that apply to Lash pursuant to this section of the Terms of Use; make available PHI necessary for you to respond to individuals' requests for access to PHI about them in the event that the PHI in Lash's possession constitutes a Designated Record Set. Questions or comments? If any provision of the Terms of Use is found to be invalid by any court having competent jurisdiction, the invalidity of such provision shall not affect the validity of the remaining provisions of the Terms and Conditions, which shall remain in full force and effect. US-DUP-1265a Complete entire form and fax the first 4 PAGES to DUPIXENT … Dupilumab (trade name: Dupixent) has been approved in Germany since May 2019 for the treatment of severe asthma in adults and children aged 12 and over. I acknowledge that by checking the Text Messaging Consent box, I expressly consent to receive text messages from or on behalf of the Program at the mobile telephone number(s) that I provide. DUPIXENT is indicated as an add-on maintenance treatment in patients with moderate-to-severe asthma aged 12 years and older with an eosinophilic phenotype or with oral corticosteroid dependent asthma. Asthma Enrollment Form Medications A-E (Cinqair®, Dupixent®) Fax Referral To: 1-800-323-2445 Phone: 1-800-237-2767 Email Referral To: [email protected] Six Simple Steps to Submitting a Referral 1 PATIENT INFORMATION (Complete or include demographic sheet) DUPIXENT ® (dupilumab) injection, for subcutaneous use Initial U.S. Approval: 2017 . are scheduled to receive any vaccinations. I also understand that the Services may be revised, changed, or terminated at any time. Be sure to check your inbox. if you are a new york prescriber, please use an original new york state prescription form. It is not known whether DUPIXENT will harm your unborn baby. The failure of any party to exercise or enforce any right or provision of the Terms of Use shall not constitute a waiver of such right or condition. Meijer Specialty Pharmacy Corporate Offices & Patient Services; 2350 Three Mile Road NW; Grand Rapids, MI 49544; Phone: 1-855-263-4537 Fax: 1-877-222-5036 National Distribution Center Asthma . I confirm that I am the subscriber for the mobile telephone number(s) provided, and I agree to notify Sanofi promptly if any of my number(s) change in the future. I further authorize the Alliance to de-identify my health information and use it in performing research, education, business analytics, marketing studies or for other commercial purposes. RECENT MAJOR CHANGES _____ Indications and Usage, Atopic Dermatitis (1.1) 03/2019 Indications and Usage, Asthma (1.2) 10/2018 Indications and Usage, CRSwNP (1.3) 06/2019 CVS Caremark Specialty Programs 2969 Mapunapuna Place Honolulu, HI 96819 Phone: 1-808-254-4414 Fax: 1-866-237- 5512 www.caremark.com DUPIXENT helps prevent severe asthma … DUPIXENT helps prevent severe asthma attacks (exacerbations) and can improve your breathing. DUPIXENT is a prescription medicine used with other asthma medicines for the maintenance treatment of moderate-to-severe eosinophilic or oral steroid dependent asthma in people aged 12 years and older whose asthma is not controlled with their current asthma medicines. Visit the Dupixent website or call 1-844-387-4936 to see if … Fill out, securely sign, print or email your Dupixent MyWay Program Enrollment Form instantly with SignNow. I understand and agree that the Alliance may use my health information for these purposes and may share my health information with my doctors, specialty pharmacies, and insurers.